Market Research Logo

Autoimmune Diseases Market in the US 2015-2019

Autoimmune Diseases Market in the US 2015-2019

About Autoimmune Diseases

Autoimmune diseases are caused by aggravation of the immune system. Autoimmune diseases can last for months or even years. Autoimmune reactions occur when the immune system produces autoantibodies that attack and destroy healthy tissues in the body rather than infectious agents. These autoantibodies cause inflammation, pain, and organ damage. It is also known as a disease of flare-ups and remissions, and can range from mild to life-threatening in severity. No cure exists for autoimmune diseases yet. Autoimmune diseases can affect the cardiovascular system, brain, nerves, musculoskeletal system, skin, lungs, kidneys, glands, or joints. They are caused by genetic, infectious, and environmental factors. According to NIH, there are more than 80 clinically different autoimmune diseases. Some of the common types of autoimmune diseases are ankylosing spondylitis, Crohn's disease, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and psoriasis.

Technavio's analysts forecast the autoimmune diseases market in the US to grow at a CAGR of 6.17% over the period 2014-2019.

Covered in this Report

The report includes the present scenario and the growth prospects of the autoimmune diseases market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of autoimmune diseases.

Technavio's report, Autoimmune Diseases Market in US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast for individual diseases as well as the overall market and pipeline landscape. The report includes a discussion of the key vendors operating in this market.

Key Vendors

  • AbbVie
  • Amgen
  • Biogen
  • F. Hoffmann-La Roche
  • Janssen Pharmaceuticals
Other Prominent Vendors
  • AB Science
  • Acorda Therapeutics
  • aTyr Pharma
  • Baxter
  • Celgene
  • Celltrion
  • Coherus BioSciences
  • Daiichi Sankyo
  • Eli Lilly
  • GlaxoSmithKline
  • HGS
  • Hospira
  • Idera
  • Immunomedics
  • ImmuPharma
  • Invion
  • Latona Life Sciences
  • MedImmune
  • Merck
  • Novartis
  • Opexa Therapeutics
  • Principia
  • Reata Pharmaceuticals
  • Regeneron
  • Sanofi
  • Sobi
  • Takeda
  • Teva
  • UCB
  • Vaccinex
  • Vitae Pharmaceuticals
Key Market Driver
  • Unmet Medical Needs
  • For a full, detailed list, view our report
Key Market Challenge
  • High Cost of Therapy
  • For a full, detailed list, view our report
Key Market Trend
  • Increase in Public Awareness
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Autoimmune Diseases Drugs Market in the US 2015-2019

Technavio recognizes the following companies as the key players in the Autoimmune Diseases Drugs Market in the US: AbbVie, Amgen, Biogen, F. Hoffmann-La Roche and Janssen Pharmaceuticals

Other Prominent Vendors in the market are: Bitdefender, Fortinet, F-Secure, G DATA Software, McAfee, Panda Security, PSafe, Sophos and Wontok

Commenting on the report, an analyst from Technavio’s team said: “Vendors are increasingly entering into alliances with universities, research institutes, and pharmaceutical companies for new drug development and to increase their market share. For instance, in 2015, Janssen-Cilag, a subsidiary of Janssen Pharmaceuticals, entered into an agreement with Monash University for the development of new medicines to treat rheumatoid arthritis and psoriasis. In 2014, MacroGenics and Takeda entered into an agreement for the development MGD010 for the treatment of systemic lupus erythematosus. In 2014, Kineta and Seattle Children's Research Institute announced the formation of an Alliance for Children's Therapeutics, a research collaboration for the development of new medicines in the treatment of autoimmune disorders such as multiple sclerosis and rheumatoid arthritis. Similarly, in 2013, Daiichi Sankyo and Amplimmune formed an alliance for the development of AMP-110, a biologic meant for the treatment of rheumatoid arthritis.”

According to the report, the high prevalence of autoimmune diseases is one of the major drivers in the market. An increasing number of people are being diagnosed with diseases such as Crohn's disease, multiple sclerosis, and rheumatoid arthritis. With the rise in the prevalence of autoimmune diseases, the demand for drugs is also increasing.Further, the report states that the complex nature of autoimmune diseases and the high cost of treatment are major challenges to the growth of the market.

Companies Mentioned

AbbVie, Amgen, Biogen, F. Hoffmann-La Roche, Janssen Pharmaceuticals, Bitdefender, Fortinet, F-Secure, G DATA Software, McAfee, Panda Security, PSafe, Sophos, Wontok

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market Overview
    • Product Offerings
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Introduction
  • Disease Overview
    • Understanding Autoimmune Diseases
    • Epidemiology
    • Etiology
    • Symptoms
    • Diagnosis
      • Medical History
      • Laboratory Examination
    • Disease Management
    • Quality of Life
  • Market Landscape
    • Market Overview
    • Market Size and Forecast
      • Table Autoimmune Diseases Drugs Market in US 2014-2019 ($ millions)
  • Pipeline Portfolio
    • Pipeline Landscape: Crohn's Disease
    • Pipeline Landscape: Multiple Sclerosis
    • Pipeline Landscape: Systemic Lupus Erythematosus
    • Five Forces Analysis
  • Market Segmentation by Type of Disease
    • Table Autoimmune Diseases Drugs Market in US by Type of Disease
    • Rheumatoid Arthritis
    • Multiple Sclerosis
    • Psoriasis
    • Crohn's Disease
    • Ankylosing Spondylitis
    • Systemic Lupus Erythematosus
      • Table Autoimmune Diseases Drugs Market by Type of Disease 2014
  • Market Segmentation by Type of Molecule
    • Table Autoimmune Diseases Drugs Market in US by Type of Molecule
    • Small Molecules
      • Biologics
  • Market Segmentation by Route of Administration
    • Table Autoimmune Diseases Drugs Market in US by Route of Administration
    • Parenteral Route
      • Oral Route
  • Rheumatoid Arthritis Drugs Market in US
    • Market Size and Forecast
      • Table Rheumatoid Arthritis Drugs Market in US 2014-2019 ($ millions)
  • Multiple Sclerosis Drugs Market in US
    • Market Size and Forecast
      • Table Multiple Sclerosis Drugs Market in US 2014-2019 ($ millions)
  • Psoriasis Drugs Market in US
    • Market Size and Forecast
      • Table Psoriasis Drugs Market in US 2014-2019 ($ millions)
  • Crohn's Disease Drugs Market in US
    • Market Size and Forecast
      • Table Crohn's Disease Drugs Market in US 2014-2019 ($ millions)
  • Ankylosing Spondylitis Drugs Market in US
    • Market Size and Forecast
      • Table Ankylosing Spondylitis Drugs Market in US 2014-2019 ($ millions)
  • Systemic Lupus Erythematosus Drugs Market in US
    • Market Size and Forecast
      • Table Systemic Lupus Erythematosus Drugs Market in US 2014-2019 ($ millions)
      • Table Autoimmune Diseases Drugs Market in US 2014-2019 ($ millions)
  • Buying Criteria
  • Market Growth Drivers
  • Drivers and Their Impact
  • Market Challenges
  • Impact of Drivers and Challenges
  • Market Trends
  • Trends and Their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Mergers and Acquisitions
    • Market Share Analysis 2014
      • AbbVie
        • Table AbbVie: Product Portfolio for Autoimmune Diseases
        • Table Humira: YoY Revenue in US 2009-2014 ($ millions)
      • Janssen Pharmaceuticals
        • Table Janssen: Product Portfolio for Autoimmune Diseases
        • Table Remicade: YoY Global Revenue of 2009-2014 ($ millions)
        • Table Simponi: YoY Global Revenue 2010-2014 ($ millions)
      • Biogen
        • Table Biogen: Product Portfolio for Autoimmune Diseases
        • Table Tysabri: YoY Revenue in US 2009-2014 ($ millions)
        • Table Avonex: Revenue in US 2011-2014 ($ millions)
        • Table Plegridy: Region-Wise Revenue 2014 ($ millions)
        • Table Tecfidera: Region-Wise Revenue 2014 ($ millions)
      • Amgen
        • Table Amgen: Product Portfolio for Autoimmune Diseases
      • F. Hoffmann-La Roche
        • Table Roche: Product Portfolio for Autoimmune Diseases
    • Other and Future Prominent Vendors
  • Key Vendor Analysis
    • AbbVie
      • Key Facts
      • Business Overview
      • Product Segmentation by Revenue 2013
        • Table AbbVie: Product Segmentation by Revenue 2013
      • Product Segmentation by Revenue 2012 and 2013
        • Table AbbVie: Product Segmentation by Revenue 2012 and 2013 ($ millions)
      • Sales by Geography
        • Table AbbVie: Sales by Geography 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
    • Amgen
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Amgen: Business Segmentation by Revenue 2013
      • Product Portfolio by Revenue 2013
        • Table Amgen: Product Portfolio by Revenue 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Amgen: Business Segmentation by Revenue 2012 and 2013 ($ billions)
      • Geographical Segmentation by Revenue 2013
        • Table Amgen: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
    • Biogen
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Biogen: Business Segmentation by Revenue 2013
      • Geographical Segmentation by Revenue 2013
        • Table Biogen: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
    • F. Hoffmann-La Roche
      • Key Facts
      • Business Overview
      • Business Segmentation
        • Table Business Segmentation of F. Hoffmann-La Roche 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
      • Sales by Geography
        • Table F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
        • Table F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
      • Business Strategy
      • Key Information
      • SWOT Analysis
    • Janssen Pharmaceuticals
      • Key Facts
      • Business Overview
      • Recent Developments
      • SWOT Analysis
  • Other Reports in the Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report